RWML
BPMC

RAFFA WEALTH MANAGEMENT, LLC’s Blueprint Medicines BPMC Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$2.13K Buy
+19
New +$2K ﹤0.01% 539
2020
Q2 		$1.56K Hold
20
– – ﹤0.01% 535
2020
Q1 		$1.17K Buy
+20
New +$1.29K ﹤0.01% 548
2019
Q3 		$1.47K Buy
+20
New +$1.73K ﹤0.01% 464

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's BPMC Position: Q4 2020 in Review

RAFFA WEALTH MANAGEMENT, LLC opened a new position in Blueprint Medicines (BPMC) in Q4 2020: 19 shares worth $2.13K. The stake represents ﹤0.01% of the portfolio and ranks #539 among its holdings. This is a return to the name: RAFFA WEALTH MANAGEMENT, LLC previously reported a position in BPMC as recently as Q2 2020.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in BPMC in Q3 2019 and has held it in 4 quarters since. 279 funds tracked by Wall St. Rank hold BPMC as of Q4 2020.

  • RAFFA WEALTH MANAGEMENT, LLC held 19 shares of Blueprint Medicines worth $2.13K as of Q4 2020.
  • Blueprint Medicines was a new RAFFA WEALTH MANAGEMENT, LLC position in Q4 2020.
  • Blueprint Medicines made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q4 2020, its #539 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Blueprint Medicines in Q3 2019 and has held it in 4 quarters since.
  • 279 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2020.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q4 2020, filed 27 Jul 2026.